Pillstats
Rx only · Tablet · Oral

Etravirine

Brands: Intelence · Etravirine

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US16 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCJ05AG04
RxCUI (US)475969
US makers7 labelers
Packages16
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$3.43$6.86$10.28$13.71Dec 2025Mar 2026Jul 2026
$11.149
Latest avg · Jul 22, 2026
-6%
Since Dec 17, 2025
7
Active US suppliers
38%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3496981.0K1.4K2025 Q12025 Q22025 Q32025 Q42026 Q1
824
Rx · 2026 Q1
56K
Units dispensed
-32%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Amneal Pharmaceuticals LLCunknown3SUPPLYING
Janssen Products LPunknown3SUPPLYING
Patriot Pharmaceuticalsunknown2SUPPLYING
AvKAREunknown2SUPPLYING
Leading Pharma, LLCunknown2SUPPLYING
Bionpharma Inc.unknown2SUPPLYING
Carnegie Pharmaceuticals LLCunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 28, 2026
    RESOLVEDShortage resolved: Etravirine Tablet (Janssen Research and Development)

    Etravirine Tablet — reported in shortage by Janssen Research and Development. Therapeutic category: Antiviral.

  • Apr 28, 2026
    SHORTAGEDrug shortage: Etravirine Tablet (Janssen Research and Development)

    Etravirine Tablet — reported in shortage by Janssen Research and Development. Therapeutic category: Antiviral.